Wang, Y., Hagiwara, S., Kazama, H., Iizuka, Y., Tanaka, N., & Tanaka, J. Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes. Wiley.
Chicago Style (17th ed.) CitationWang, Yan-Hua, Shotaro Hagiwara, Hiroshi Kazama, Yuki Iizuka, Norina Tanaka, and Junji Tanaka. Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity Against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes. Wiley.
MLA (9th ed.) CitationWang, Yan-Hua, et al. Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity Against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes. Wiley.
Warning: These citations may not always be 100% accurate.